Ignite Creation Date:
2024-05-06 @ 7:28 PM
Last Modification Date:
2024-10-26 @ 3:07 PM
Study NCT ID:
NCT06023641
Status:
RECRUITING
Last Update Posted:
2024-05-08
First Post:
2023-08-27
Brief Title:
Treatment of Newly Diagnosed Rhabdomyosarcoma Using Molecular Risk Stratification and Liposomal Irinotecan Based Therapy in Children With Intermediate and High Risk Disease
Sponsor:
St Jude Childrens Research Hospital
Organization:
St Jude Childrens Research Hospital
Organization Data
Organization:
St Jude Childrens Research Hospital
Class:
OTHER
Study ID:
RMS2021
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
St Jude Childrens Research Hospital
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None